Rosacea Subtype 1 (Erythematotelangiectatic) (DBCOND0058602)

Identifiers

Synonyms

Rosacea, Erythematotelangiectatic / Erythematous (Type One) Rosacea / Erythematous Rosacea / Erythematotelangiectatic Rosacea / Erythemato-telangiectatic Rosacea / Acne rosacea, erythematous telangiectatic type (disorder)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06434519	Metronidazole SC Penetrance With Moisturizers	Metronidazole	treatment	Not Available	recruiting
NCT05616923	Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea	Trametinib	treatment	1	completed
NCT01186068	Dose Response Study of Patients With Erythematous Rosacea	Tetrasul	treatment	2	completed
NCT00697541	Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%	Brimonidine Col-118 Water	treatment	2	completed
NCT06331533	Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea	Botulinum toxin type A Sodium chloride	treatment	4	completed
NCT03708263	Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea	No drug interventions	treatment	Not Available	terminated
NCT02268474	Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea	No drug interventions	treatment	Not Available	completed
NCT00945373	Combination Therapy for the Treatment of Rosacea	Dobesilic acid	treatment	1	completed
NCT00989014	Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea	No drug interventions	treatment	2	completed
NCT01045551	Open Label Pilot Study of Apremilast in Treatment of Rosacea	Apremilast	treatment	2	completed
NCT05360251	Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematotelangiectatic Rosacea	No drug interventions	treatment	Not Available	unknown_status
NCT04153188	Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea	Oxymetazoline	treatment	4	completed
NCT02393937	A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea	Metronidazole	treatment	3	completed
NCT02052999	Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients	Metronidazole PAC-14028	treatment	2	completed
NCT01756027	Feasibility Study: Ulthera System for the Treatment of Rosacea	No drug interventions	treatment	Not Available	completed
NCT02144181	Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea	No drug interventions	treatment	Not Available	completed
NCT01666509	Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)	No drug interventions	treatment	Not Available	completed
NCT01449591	Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients	BFH772 Metronidazole	treatment	2	completed